Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer
Artificial Intelligence Surgery · 2023 · 3 (1) · 14-26
DOI: 10.20517/ais.2022.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Intelligence Surgery, 2023. Verfasst von Daniela R Tovar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Radiation Oncology, The University of Texas, Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is the third most lethal cancer in the United States, with a 5-year life expectancy of 11%. Most symptoms manifest at an advanced stage of the disease when surgery is no longer appropriate. The dire prognosis of PDAC warrants new strategies to improve the outcomes of patients, and early detection has garnered significant attention. However, early detection of PDAC is most often incidental, emphasizing the importance of developing new early detection screening strategies. Due to the low incidence of the disease in the general population, much of the focus for screening has turned to individuals at high risk of PDAC. This enriches the screening population and balances the risks associated with pancreas interventions. The cancers that are found in these high-risk individuals by MRI and/or EUS screening show favorable 73% 5-year overall survival. Even with the emphasis on screening in enriched high-risk populations, only a minority of incident cancers are detected this way. One strategy to improve early detection outcomes is to integrate artificial intelligence (AI) into biomarker discovery and risk models. This expert review summarizes recent publications that have developed AI algorithms for the applications of risk stratification of PDAC using radiomics and electronic health records. Furthermore, this review illustrates the current uses of radiomics and biomarkers in AI for early detection of PDAC. Finally, various challenges and potential solutions are highlighted regarding the use of AI in medicine for early detection purposes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Radiation Oncology, The University of Texas, Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Radiology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Radiology, The University of Texas, Anderson Cancer Center, Houston, TX 77030, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Tovar, D. R., Rosenthal, M. H., Maitra, A., & Koay, E. J. (2023). Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. Artificial Intelligence Surgery, 3(1), 14-26. https://doi.org/10.20517/ais.2022.38
Vancouver
Tovar DR, Rosenthal MH, Maitra A, Koay EJ. Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. Artificial Intelligence Surgery. 2023;3(1):14-26. doi:10.20517/ais.2022.38
BibTeX
@article{Tovar2023,
author = {Tovar, Daniela R and Rosenthal, Michael H and Maitra, Anirban and Koay, Eugene J},
title = {Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer},
journal = {Artificial Intelligence Surgery},
year = {2023},
volume = {3},
number = {1},
pages = {14--26},
doi = {10.20517/ais.2022.38}
}
EUVIMED